DudeDiligence.

FINANCING

Who is raising money: selling new shares, filing room to sell more later, or borrowing. New shares give every holder a smaller slice.

Shares soldSold over timeRoom to sell laterBorrowingReverse splitThe stock since the filing

Key

Shares soldSold over timeRoom to sell laterBorrowingReverse splitThe stock since the filing

Newest first. A company with several filings is one row; open it for each.

  1. APVOAptevo Therapeutics Inc.Unregistered sale of shares, 8-K item 3.02size not available−38.8%8-K ↗
  2. FATEFate Therapeutics, Inc.At-the-market programme, with Leerink Partners$100.0M89% of value−31.4%424B5 ↗
  3. OPHCOptimumBank Holdings, Inc.Private placement$10.0M8.0% of value−10.4%8-K ↗
  4. LHSWLianhe Sowell International Group LtdShelf$200.0M−39.3%F-3 ↗
  5. TLPHTalphera, Inc.Shelf$150.0M−24.1%S-3 ↗
  6. AIROAIRO Group Holdings, Inc.At-the-market programme and shelf$100.0M−36.0%
  7. GRMLGreenland Mines LtdUnregistered sale of shares, 8-K item 3.02size not available−22.3%8-K ↗
  8. KITTNauticus Robotics, Inc.Registration for an offeringsize not available−46.5%S-1 ↗
  9. PEPGPepGen Inc.Public offering, 25.0M shares at $5.00$125.0M35% of value−25.0%424B5 ↗
  10. SPCEVirgin Galactic Holdings, Inc.At-the-market programme, with Jefferies$250.0M1.6x value−61.0%424B5 ↗
  11. KALAKALA BIO, Inc.Reverse split, 1-for-30+1580.1%8-K ↗
  12. CADLCandel Therapeutics, Inc.At-the-market programme, with Jefferies$50.0M13% of value−39.9%424B5 ↗
  13. SLXNSilexion Therapeutics CorpReverse split, 1-for-24−50.8%8-K ↗
  14. LFMDLifeMD, Inc.Notes and private placement$12.5M18% of value−12.7%
  15. LCTXLineage Cell Therapeutics, Inc.Unregistered sale of shares, 8-K item 3.02size not available−22.1%8-K ↗
  16. VIRVir Biotechnology, Inc.Shelf, automatic (S-3ASR)no dollar limit−30.8%S-3ASR ↗
  17. HAOHaoxi Health Technology LimitedShelf$180.0M−13.7%F-3 ↗
  18. NXGLNEXGEL, Inc.Unregistered sale of shares, 8-K item 3.02size not available−26.4%8-K ↗
  19. RETOReTo Eco-Solutions, Inc.Public offeringsize not available−34.9%424B5 ↗
  20. MGTXMeiraGTx Holdings plcAt-the-market programme and shelf$100.0M13% of value−17.6%
  21. ABSIAbsci CorporationShelf, automatic (S-3ASR)no dollar limit−25.8%S-3ASR ↗
  22. PROKProKidney Corp.At-the-market programme, with Jefferies$200.0M48% of value−8.0%424B5 ↗
  23. PRMEPrime Medicine, Inc.Public offering, 35.7M shares at $3.50$125.0M16% of value−17.4%424B5 ↗
  24. STIMNeuronetics, Inc.Public offering, 18.8M shares at $1.60$30.0M25% of value−22.8%424B5 ↗
  25. NYAXNayax Ltd.Shelf, automatic (S-3ASR)no dollar limit−11.3%F-3ASR ↗
  26. VORVor Biopharma Inc.Private placement, 2.30M sharessize not available−4.5%8-K ↗
  27. GMHSGamehaus Holdings Inc.Public offeringsize not available+13.0%424B5 ↗
  28. FOXXFoxx Development Holdings Inc.Unregistered sale of shares, 8-K item 3.02size not available−5.1%8-K ↗
  29. ATXGAddentax Group Corp.Private placement, 313K shares at $4.80$1.5M39% of value−15.0%8-K ↗
  30. GOVXGeoVax Labs, Inc.Reverse split, 1-for-24−16.2%8-K ↗
  31. LICNLichen International LimitedPublic offering, 17.5M shares at $0.20$3.5M+2971.4%424B5 ↗
  32. SEVAptera Motors Corp.Registered direct offering and public offering$6.0M8.4% of value−2.5%
  33. VIVKVivakor, Inc.Unregistered sale of shares, 8-K item 3.02size not available−23.2%8-K ↗
  34. NHPNational Healthcare Properties, Inc.At-the-market programme$300.0M20% of value−5.9%
  35. ATLCAtlanticus Holdings CorporationShelf$1.00B−3.4%S-3 ↗
  36. CYABCyabra, Inc.Notes$1.5M62% of value−21.6%8-K ↗
  37. KURAKura Oncology, Inc.At-the-market programme and shelf$150.0M24% of value−8.7%
  38. FWDIForward Industries, Inc.At-the-market programme, with Cantor Fitzgerald$4.00B−37.4%8-K ↗
  39. TGHLThe Growhub LimitedRegistration for an offeringsize not available−27.1%F-1 ↗
  40. ATRAAtara Biotherapeutics, Inc.At-the-market programme and shelf$200.0M−21.9%
  41. TELATELA Bio, Inc.Shelf$150.0M−13.9%S-3 ↗
  42. MTRIMentari Therapeutics, Inc.Private placement$490.0M57% of value8-K ↗
  43. SNTISenti Biosciences Holdings, Inc.Unregistered sale of shares, 8-K item 3.02size not available−62.0%8-K ↗